Skip to content

Efficacy of electroacupuncture on male patients undergoing ureteral stent removal under local anesthesia: a randomized single-blind placebo-controlled single-center clinical trial

Efficacy of electroacupuncture on male patients undergoing ureteral stent removal under local anesthesia: a randomized single-blind placebo-controlled single-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000222
Enrollment
Unknown
Registered
2025-02-08
Start date
2025-02-15
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stone

Interventions

Experimental Group:electroacupuncture
Control group:sham electroacupunture

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) To voluntarily participate in the study I or his legal representative signed a written informed consent. (2) The patients were over 18 years old (including 18 years old) and male. (3) CT examination of the urinary system confirmed that the ureteral stent was in place without obvious residual stones (long diameter =3mm). (4) The ureteral stent was indwelling for 14±2 days and the first ureteral stent removal was performed.

Exclusion criteria

Exclusion criteria: (1) in the stage of acute genitourinary infection or fever. (2) postoperative residual stones (long diameter =3mm). (3) surgical history of solitary kidney urethra and ureter malformation. (4) Continuous use of anti-anxiety or analgesic drugs (use of anti-anxiety drugs or analgesics for more than 1 week in the past 3 months). (5) fear of acupuncture operators. (6) Participants who participated in other clinical trials within 3 months before enrollment. (7) other conditions considered by the investigators to be inappropriate for participation in the trial.

Design outcomes

Secondary

MeasureTime frame
Adverse events during surgery and within 1 week after surgery were recorded;Visual Analogue Scale for anxiety (VAS-a) score at the beginning of surgery and at the end of surgery;NRS AUC 15 min after completion of surgery-60 min after completion of surgery;Changes of salivary cortisol at the completion of surgery compared with that at the beginning of surgery;The fluctuation of blood pressure and heart rate at the end of operation compared with that at the beginning of operation;Assessment of external manifestations of pain during surgery;Assessment of anesthesia satisfaction 60 min after completion of surgery;

Primary

MeasureTime frame
The most severe pain level experienced during the procedure (NRS max);

Countries

China

Contacts

Public ContactChuanmin Chu

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

drchucm@163.com13816176407

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026